Skip to main content

Articles

Page 7 of 15

  1. A considerable amount of research has discussed whether autism and psychiatric/neurodevelopmental conditions in general are best described categorically or dimensionally. In recent years, finite mixture models...

    Authors: Ahmad Abu-Akel, Carrie Allison, Simon Baron-Cohen and Dietmar Heinke
    Citation: Molecular Autism 2019 10:24
  2. Angelman syndrome (AS) is a severe neurodevelopmental disorder caused by mutations affecting UBE3A gene expression. Previous studies in mice revealed distinct critical periods during neurodevelopment in which rea...

    Authors: Monica Sonzogni, Johanna Hakonen, Mireia Bernabé Kleijn, Sara Silva-Santos, Matthew C. Judson, Benjamin D. Philpot, Geeske M. van Woerden and Ype Elgersma
    Citation: Molecular Autism 2019 10:23
  3. Autism spectrum disorders (ASD) are characterized by abnormal neurodevelopment, genetic, and environmental risk factors, as well as immune dysfunctions. Several lines of evidence suggest alterations in innate ...

    Authors: Meriem Bennabi, Nadine Tarantino, Alexandru Gaman, Isabelle Scheid, Rajagopal Krishnamoorthy, Patrice Debré, Arthur Bouleau, Mireille Caralp, Sonia Gueguen, Myriam Ly Le-Moal, Manuel Bouvard, Anouck Amestoy, Richard Delorme, Marion Leboyer, Ryad Tamouza and Vincent Vieillard
    Citation: Molecular Autism 2019 10:22
  4. Fragile X syndrome (FXS) is a common monogenic cause of intellectual disability with autism features. While it is caused by loss of the FMR1 product (FMRP), mosaicism for active and inactive FMR1 alleles, includi...

    Authors: Emma K. Baker, Marta Arpone, Solange M. Aliaga, Lesley Bretherton, Claudine M. Kraan, Minh Bui, Howard R. Slater, Ling Ling, David Francis, Matthew F. Hunter, Justine Elliott, Carolyn Rogers, Michael Field, Jonathan Cohen, Kim Cornish, Lorena Santa Maria…
    Citation: Molecular Autism 2019 10:21
  5. Recent studies indicate increased autistic traits in musicians with absolute pitch and a higher proportion of absolute pitch in people with autism. Theoretical accounts connect both of these with shared neural...

    Authors: T. Wenhart, R. A. I. Bethlehem, S. Baron-Cohen and E. Altenmüller
    Citation: Molecular Autism 2019 10:20
  6. Autism spectrum disorders (ASD) affect around 1.5% of people worldwide. Symptoms start around age 2, when children fail to maintain eye contact and to develop speech and other forms of communication. Disturban...

    Authors: Elisa Maria Guimarães-Souza, Christina Joselevitch, Luiz Roberto G. Britto and Silvana Chiavegatto
    Citation: Molecular Autism 2019 10:19
  7. Non-suicidal self-injury (NSSI) describes a phenomenon where individuals inflict deliberate pain and tissue damage to their bodies. Self-injurious behaviour is especially prevalent across the autism spectrum, ...

    Authors: R. L. Moseley, N. J. Gregory, P. Smith, C. Allison and S. Baron-Cohen
    Citation: Molecular Autism 2019 10:18
  8. Epidemiological and clinical evidence points to cancer as a comorbidity in people with autism spectrum disorders (ASD). A significant overlap of genes and biological processes between both diseases has also be...

    Authors: Jaume Forés-Martos, Ferrán Catalá-López, Jon Sánchez-Valle, Kristina Ibáñez, Héctor Tejero, Helena Palma-Gudiel, Joan Climent, Vera Pancaldi, Lourdes Fañanás, Celso Arango, Mara Parellada, Anaïs Baudot, Daniel Vogt, John L. Rubenstein, Alfonso Valencia and Rafael Tabarés-Seisdedos
    Citation: Molecular Autism 2019 10:17
  9. Increasing attention is being paid to the higher prevalence of boys with Autism Spectrum Disorder (ASD) and to the implications of this ratio discrepancy on our understanding of autism in girls. One recent ave...

    Authors: Philippine Geelhand, Philippe Bernard, Olivier Klein, Bob van Tiel and Mikhail Kissine
    Citation: Molecular Autism 2019 10:16
  10. Mutations of the SCN2A gene encoding a voltage-gated sodium channel alpha-II subunit Nav1.2 are associated with neurological disorders such as epilepsy, autism spectrum disorders, intellectual disability, and sch...

    Authors: Tetsuya Tatsukawa, Matthieu Raveau, Ikuo Ogiwara, Satoko Hattori, Hiroyuki Miyamoto, Emi Mazaki, Shigeyoshi Itohara, Tsuyoshi Miyakawa, Mauricio Montal and Kazuhiro Yamakawa
    Citation: Molecular Autism 2019 10:15
  11. Narrative abilities are linked to social impairment in autism spectrum disorder (ASD), such that reductions in words about cognitive processes (e.g., think, know) are thought to reflect underlying deficits in soc...

    Authors: Jaclin Boorse, Meredith Cola, Samantha Plate, Lisa Yankowitz, Juhi Pandey, Robert T. Schultz and Julia Parish-Morris
    Citation: Molecular Autism 2019 10:14
  12. Autism spectrum disorder (ASD) is characterised by persisting difficulties in everyday functioning. Adaptive behaviour is heterogeneous across individuals with ASD, and it is not clear to what extent early dev...

    Authors: Giorgia Bussu, Emily J. H. Jones, Tony Charman, Mark H. Johnson and Jan K. Buitelaar
    Citation: Molecular Autism 2019 10:13
  13. Autism is a highly varied and heritable neurodevelopmental condition, and common variants explain approximately 50% of the genetic variance of autism. One of the genes implicated in autism is the oxytocin rece...

    Authors: Florina Uzefovsky, Richard A. I. Bethlehem, Simone Shamay-Tsoory, Amber Ruigrok, Rosemary Holt, Michael Spencer, Lindsay Chura, Varun Warrier, Bhismadev Chakrabarti, Ed Bullmore, John Suckling, Dorothea Floris and Simon Baron-Cohen
    Citation: Molecular Autism 2019 10:12
  14. The core features of autism spectrum disorder (ASD) are easily recognizable in non-structured clinical and real-life situations. The features are often difficult to capture in structured laboratory settings, a...

    Authors: Anne L. Høyland, Terje Nærland, Morten Engstrøm, Tonje Torske, Stian Lydersen and Ole A. Andreassen
    Citation: Molecular Autism 2019 10:10
  15. Current global estimates suggest the proportion of the population with autism spectrum disorder (ASD) who have intellectual disability (ID) is approximately 50%. Our objective was to ascertain the existence of...

    Authors: Ginny Russell, William Mandy, Daisy Elliott, Rhianna White, Tom Pittwood and Tamsin Ford
    Citation: Molecular Autism 2019 10:9
  16. Of the many genetic mutations known to increase the risk of autism spectrum disorder, a large proportion cluster upon synaptic proteins. One such family of presynaptic proteins are the neurexins (NRXN), and re...

    Authors: Eleftheria Pervolaraki, Adam L. Tyson, Francesca Pibiri, Steven L. Poulter, Amy C. Reichelt, R. John Rodgers, Steven J. Clapcote, Colin Lever, Laura C. Andreae and James Dachtler
    Citation: Molecular Autism 2019 10:8
  17. Autism prevalence in the West is approximately 1% of school age children. Autism prevalence in China has been reported to be lower than in the West. This is likely due to at least two reasons: (1) most studies...

    Authors: Xiang Sun, Carrie Allison, Liping Wei, Fiona E. Matthews, Bonnie Auyeung, Yu Yu Wu, Sian Griffiths, Jie Zhang, Simon Baron-Cohen and Carol Brayne
    Citation: Molecular Autism 2019 10:7
  18. Autism spectrum disorders (ASD) exhibit two clusters of core symptoms, i.e., social and communication impairment, and repetitive behaviors and sensory abnormalities. Our previous study demonstrated that TBR1, ...

    Authors: Tzyy-Nan Huang, Tzu-Li Yen, Lily R. Qiu, Hsiu-Chun Chuang, Jason P. Lerch and Yi-Ping Hsueh
    Citation: Molecular Autism 2019 10:5
  19. Sensory processing difficulties are common across neurodevelopmental disorders. Thus, reliable measures are needed to understand the biological underpinnings of these differences. This study aimed to define a ...

    Authors: Teresa Tavassoli, Anne Brandes-Aitken, Robyn Chu, Lisa Porter, Sarah Schoen, Lucy Jane Miller, Molly Rae Gerdes, Julia Owen, Pratik Mukherjee and Elysa J. Marco
    Citation: Molecular Autism 2019 10:4
  20. Autism spectrum disorder (ASD) is currently estimated to affect more than 1% of the world population. For people with ASD, gastrointestinal (GI) distress is a commonly reported but a poorly understood co-occur...

    Authors: David M. James, Robert A. Kozol, Yuji Kajiwara, Adam L. Wahl, Emily C. Storrs, Joseph D. Buxbaum, Mason Klein, Baharak Moshiree and Julia E. Dallman
    Citation: Molecular Autism 2019 10:3
  21. The endocannabinoid system (ECS) is a major regulator of synaptic plasticity and neuromodulation. Alterations of the ECS have been demonstrated in several animal models of autism spectrum disorder (ASD). In so...

    Authors: Adi Aran, Maya Eylon, Moria Harel, Lola Polianski, Alina Nemirovski, Sigal Tepper, Aviad Schnapp, Hanoch Cassuto, Nadia Wattad and Joseph Tam
    Citation: Molecular Autism 2019 10:2
  22. Evidence has indicated that some non-inherited factors such as exposure to environmental pollutants are associated with neurodevelopment disorders like autism spectrum disorder (ASD). Studies report that endoc...

    Authors: Manhai Long, Mandana Ghisari, Lisbeth Kjeldsen, Maria Wielsøe, Bent Nørgaard-Pedersen, Erik Lykke Mortensen, Morsi W. Abdallah and Eva C. Bonefeld-Jørgensen
    Citation: Molecular Autism 2019 10:1
  23. Functional neuroimaging research in autism spectrum disorder has reported patterns of decreased long-range, within-network, and interhemispheric connectivity. Research has also reported increased corticostriat...

    Authors: Terisa P. Gabrielsen, Jeff S. Anderson, Kevin G. Stephenson, Jonathan Beck, Jace B. King, Ryan Kellems, David N. Top Jr, Nicholas C. C. Russell, Emily Anderberg, Rebecca A. Lundwall, Blake Hansen and Mikle South
    Citation: Molecular Autism 2018 9:67
  24. Neuroglial cells that provide homeostatic support and form defence of the nervous system contribute to all neurological disorders. We analyzed three major types of neuroglia, astrocytes, oligodendrocytes, and ...

    Authors: Maria Rosanna Bronzuoli, Roberta Facchinetti, Davide Ingrassia, Michela Sarvadio, Sara Schiavi, Luca Steardo, Alexei Verkhratsky, Viviana Trezza and Caterina Scuderi
    Citation: Molecular Autism 2018 9:66
  25. Mutations in CHD8, chromodomain helicase DNA-binding protein 8, are among the most replicated and common findings in genetic studies of autism spectrum disorder (ASD). The CHD8 protein is believed to act as a tra...

    Authors: Qiong Xu, Yuan-yuan Liu, Xiaoming Wang, Guo-he Tan, Hui-ping Li, Samuel W. Hulbert, Chun-yang Li, Chun-chun Hu, Zhi-qi Xiong, Xiu Xu and Yong-hui Jiang
    Citation: Molecular Autism 2018 9:65
  26. We previously performed targeted sequencing of autism risk genes in probands from the Autism Clinical and Genetic Resources in China (ACGC) (phase I). Here, we expand this analysis to a larger cohort of patien...

    Authors: Hui Guo, Tianyun Wang, Huidan Wu, Min Long, Bradley P. Coe, Honghui Li, Guanglei Xun, Jianjun Ou, Biyuan Chen, Guiqin Duan, Ting Bai, Ningxia Zhao, Yidong Shen, Yun Li, Yazhe Wang, Yu Zhang…
    Citation: Molecular Autism 2018 9:64
  27. Animal models for neurodevelopmental disorders (NDD) generally rely on a single genetic mutation on a fixed genetic background. Recent human genetic studies however indicate that a clinical diagnosis with Auti...

    Authors: Remco T. Molenhuis, Hilgo Bruining, Myrna J. V. Brandt, Petra E. van Soldt, Hanifa J. Abu-Toamih Atamni, J. Peter H. Burbach, Fuad A. Iraqi, Richard F. Mott and Martien J. H. Kas
    Citation: Molecular Autism 2018 9:63
  28. The corpus callosum is implicated in the pathophysiology of autism spectrum disorder (ASD). However, specific structural deficits and underlying mechanisms are yet to be well defined.

    Authors: Yu Veronica Sui, Jeffrey Donaldson, Laura Miles, James S. Babb, Francisco Xavier Castellanos and Mariana Lazar
    Citation: Molecular Autism 2018 9:62
  29. Gut microbiota has the capacity to impact the regular function of the brain, which can in turn affect the composition of microbiota. Autism spectrum disorder (ASD) patients suffer from gastrointestinal problem...

    Authors: Fang Liu, Kayla Horton-Sparks, Vanessa Hull, Robert W. Li and Verónica Martínez-Cerdeño
    Citation: Molecular Autism 2018 9:61
  30. Hyperserotonemia in the brain is suspected to be an endophenotype of autism spectrum disorder (ASD). Reducing serotonin levels in the brain through modulation of serotonin transporter function may improve ASD ...

    Authors: Miho Tanaka, Atsushi Sato, Shinya Kasai, Yoko Hagino, Hiroko Kotajima-Murakami, Hirofumi Kashii, Yukio Takamatsu, Yasumasa Nishito, Masumi Inagaki, Masashi Mizuguchi, F. Scott Hall, George R. Uhl, Dennis Murphy, Ichiro Sora and Kazutaka Ikeda
    Citation: Molecular Autism 2018 9:60
  31. Pioglitazone is a promising compound for treatment of core autism spectrum disorder (ASD) symptoms as it targets multiple relevant pathways, including immune system alterations.

    Authors: Lucia Capano, Annie Dupuis, Jessica Brian, Deepali Mankad, Lisa Genore, Rianne Hastie Adams, Sharon Smile, Toni Lui, Dina Odrobina, Jane A. Foster and Evdokia Anagnostou
    Citation: Molecular Autism 2018 9:59
  32. The majority of previous research into restricted and repetitive behaviours (RRBs) has focussed on children, partly due to a lack of suitable measures for RRBs in adults. This study aimed to explore the psycho...

    Authors: Sarah L. Barrett, Mirko Uljarević, Catherine R. G. Jones and Susan R. Leekam
    Citation: Molecular Autism 2018 9:58
  33. Autism spectrum disorders (ASD) are neurodevelopmental disorders characterized by three core symptoms that include social interaction deficits, cognitive inflexibility, and communication disorders. They have b...

    Authors: Nisim Perets, Stav Hertz, Michael London and Daniel Offen
    Citation: Molecular Autism 2018 9:57
  34. Altered neuronal development is discussed as the underlying pathogenic mechanism of autism spectrum disorders (ASD). Copy number variations of 16p11.2 have recurrently been identified in individuals with ASD. ...

    Authors: Denise Haslinger, Regina Waltes, Afsheen Yousaf, Silvia Lindlar, Ines Schneider, Chai K. Lim, Meng-Miao Tsai, Boyan K. Garvalov, Amparo Acker-Palmer, Nicolas Krezdorn, Björn Rotter, Till Acker, Gilles J. Guillemin, Simone Fulda, Christine M. Freitag and Andreas G. Chiocchetti
    Citation: Molecular Autism 2018 9:56
  35. There is a global need for brief screening instruments that can identify key indicators for autism to support frontline professionals in their referral decision-making. Although a universal set of conditions, ...

    Authors: Sophie Carruthers, Emma Kinnaird, Alokananda Rudra, Paula Smith, Carrie Allison, Bonnie Auyeung, Bhismadev Chakrabarti, Akio Wakabayashi, Simon Baron-Cohen, Ioannis Bakolis and Rosa A Hoekstra
    Citation: Molecular Autism 2018 9:52
  36. Loss of UBE3A causes Angelman syndrome, whereas excess UBE3A activity appears to increase the risk for autism. Despite this powerful association with neurodevelopmental disorders, there is still much to be lea...

    Authors: Alain C. Burette, Matthew C. Judson, Alissa N. Li, Edward F. Chang, William W. Seeley, Benjamin D. Philpot and Richard J. Weinberg
    Citation: Molecular Autism 2018 9:54
  37. Savant syndrome is a condition where prodigious talent can co-occur with developmental conditions such as autism spectrum conditions (autism). It is not yet clear why some autistic people develop savant skills...

    Authors: James E A Hughes, Jamie Ward, Elin Gruffydd, Simon Baron-Cohen, Paula Smith, Carrie Allison and Julia Simner
    Citation: Molecular Autism 2018 9:53
  38. Rapid automatized naming (RAN; naming of familiar items presented in an array) is a task that taps fundamental neurocognitive processes that are affected in a number of complex psychiatric conditions. Deficits...

    Authors: Kritika Nayar, Peter C Gordon, Gary E Martin, Abigail L Hogan, Chelsea La Valle, Walker McKinney, Michelle Lee, Elizabeth S Norton and Molly Losh
    Citation: Molecular Autism 2018 9:51
  39. Many young people with autism spectrum disorder (ASD) experience emotional and behavioural problems. However, the causes of these co-occurring difficulties are not well understood. Perceptual processing atypic...

    Authors: Virginia Carter Leno, Susie Chandler, Pippa White, Isabel Yorke, Tony Charman, Andrew Pickles and Emily Simonoff
    Citation: Molecular Autism 2018 9:50
  40. Histological evidence suggests that autism spectrum disorder (ASD) is accompanied by a reduced integrity of the grey-white matter boundary. This has also recently been confirmed by a structural neuroimaging st...

    Authors: Caroline Mann, Anke Bletsch, Derek Andrews, Eileen Daly, Clodagh Murphy, Declan Murphy and Christine Ecker
    Citation: Molecular Autism 2018 9:49
  41. Autism spectrum disorders (ASDs) are a heterogeneous group of behaviorally defined disorders and are associated with hundreds of rare genetic mutations and several environmental risk factors. Mouse models of s...

    Authors: Emily A. Brown, Jonathan D. Lautz, Tessa R. Davis, Edward P. Gniffke, Alison A. W. VanSchoiack, Steven C. Neier, Noah Tashbook, Chiara Nicolini, Margaret Fahnestock, Adam G. Schrum and Stephen E. P. Smith
    Citation: Molecular Autism 2018 9:48
  42. Angelman syndrome (AS) is a neurodevelopmental disorder caused by mutations affecting UBE3A function. AS is characterized by intellectual disability, impaired motor coordination, epilepsy, and behavioral abnor...

    Authors: Monica Sonzogni, Ilse Wallaard, Sara Silva Santos, Jenina Kingma, Dorine du Mee, Geeske M. van Woerden and Ype Elgersma
    Citation: Molecular Autism 2018 9:47
  43. A growing body of anecdotal evidence indicates that the use of robots may provide unique opportunities for assisting children with autism spectrum disorders (ASD). However, previous studies investigating the e...

    Authors: Hirokazu Kumazaki, Yuichiro Yoshikawa, Yuko Yoshimura, Takashi Ikeda, Chiaki Hasegawa, Daisuke N. Saito, Sara Tomiyama, Kyung-min An, Jiro Shimaya, Hiroshi Ishiguro, Yoshio Matsumoto, Yoshio Minabe and Mitsuru Kikuchi
    Citation: Molecular Autism 2018 9:46
  44. Angelman syndrome (AS) is a severe neurodevelopmental disorder lacking effective therapies. AS is caused by mutations in ubiquitin protein ligase E3A (UBE3A), which is genomically imprinted such that only the mat...

    Authors: Hyeong-Min Lee, Ellen P. Clark, M. Bram Kuijer, Mark Cushman, Yves Pommier and Benjamin D. Philpot
    Citation: Molecular Autism 2018 9:45
  45. Lowe syndrome (LS) is a rare genetic disorder caused by loss of function mutations in the X-linked gene, OCRL, which codes for inositol polyphosphate 5-phosphatase. LS is characterized by the triad of congenital ...

    Authors: Jesse Barnes, Franklin Salas, Ryan Mokhtari, Hedwig Dolstra, Erika Pedrosa and Herbert M. Lachman
    Citation: Molecular Autism 2018 9:44
  46. Recent literatures indicate that maternal hormone exposure is a risk factor for autism spectrum disorder (ASD). We hypothesize that prenatal progestin exposure may counteract the neuroprotective effect of estr...

    Authors: Weiguo Xie, Xiaohu Ge, Ling Li, Athena Yao, Xiaoyan Wang, Min Li, Xiang Gong, Zhigang Chu, Zhe Lu, Xiaodong Huang, Yun Jiao, Yifei Wang, Meifang Xiao, Haijia Chen, Wei Xiang and Paul Yao
    Citation: Molecular Autism 2018 9:43
  47. Research has shown high rates of suicidality in autism spectrum conditions (ASC), but there is lack of research into why this is the case. Many common experiences of autistic adults, such as depression or unemplo...

    Authors: Sarah Cassidy, Louise Bradley, Rebecca Shaw and Simon Baron-Cohen
    Citation: Molecular Autism 2018 9:42

Annual Journal Metrics

  • 2022 Citation Impact
    6.2 - 2-year Impact Factor
    7.2 - 5-year Impact Factor
    1.690 - SNIP (Source Normalized Impact per Paper)
    1.647 - SJR (SCImago Journal Rank)

    2022 Speed
    8 days submission to first editorial decision for all manuscripts (Median)
    133 days submission to accept (Median)

    2022 Usage 
    962,002 downloads
    12,911 Altmetric mentions